173 related articles for article (PubMed ID: 33854626)
1. Methylated
Zhao G; Liu X; Liu Y; Ma Y; Yang J; Li H; Xiong S; Fei S; Zheng M; Zhao X
J Cancer; 2021; 12(9):2665-2672. PubMed ID: 33854626
[No Abstract] [Full Text] [Related]
2. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
[TBL] [Abstract][Full Text] [Related]
3. Aberrant DNA Methylation of
Zhao G; Liu X; Liu Y; Li H; Ma Y; Li S; Zhu Y; Miao J; Xiong S; Fei S; Zheng M
Front Genet; 2020; 11():643. PubMed ID: 32625237
[TBL] [Abstract][Full Text] [Related]
4. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
[TBL] [Abstract][Full Text] [Related]
6. The stool
Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
8. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.
Zhang W; Yang C; Wang S; Xiang Z; Dou R; Lin Z; Zheng J; Xiong B
Cancer Manag Res; 2021; 13():3601-3617. PubMed ID: 33958894
[TBL] [Abstract][Full Text] [Related]
9. Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection.
Chen Z; Zhao G; Wang K; Wang X; Ma Y; Xiong S; Zheng M; Fei S
J Cancer; 2021; 12(12):3678-3685. PubMed ID: 33995643
[No Abstract] [Full Text] [Related]
10. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
11. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
[TBL] [Abstract][Full Text] [Related]
12. Stool DNA Test of Methylated
Niu F; Wen J; Fu X; Li C; Zhao R; Wu S; Yu H; Liu X; Zhao X; Liu S; Wang X; Wang J; Zou H
Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1411-1419. PubMed ID: 28619831
[No Abstract] [Full Text] [Related]
13. A simplified multiplex methylated DNA testing for early detection of colorectal cancer in stool DNA.
Dai Y; Zhao G; Yang J; Zhou X; Xiong S; Lu X; Gao L; Wu J; Xu Z; Fei S; Zheng M; Xu H
BMC Gastroenterol; 2022 Oct; 22(1):428. PubMed ID: 36203138
[TBL] [Abstract][Full Text] [Related]
14. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
[TBL] [Abstract][Full Text] [Related]
15. Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms.
Zeng T; Huang Z; Yu X; Zheng L; Liu T; Tian B; Xiao S; Huang J
Front Oncol; 2023; 13():1166796. PubMed ID: 37621691
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Methylated
Cao Y; Zhao G; Cao Y; Chen Z; Liu X; Yuan M; Yang J; Wang X; Ma Y; Liu Z; Xiong S; Zheng M; Fei S
Front Oncol; 2021; 11():647066. PubMed ID: 33968748
[TBL] [Abstract][Full Text] [Related]
18. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer.
Su WC; Kao WY; Chang TK; Tsai HL; Huang CW; Chen YC; Li CC; Hsieh YC; Yeh HJ; Chang CC; Wang JY
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33393623
[TBL] [Abstract][Full Text] [Related]
19. The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses.
Yue C; Zhang Y; Wang Y; Zhang Z; Zhang M; Wang H; Chen W; Shang Z; Xin Y; Zhang X; Zhang Y
Front Med (Lausanne); 2022; 9():753545. PubMed ID: 35372441
[TBL] [Abstract][Full Text] [Related]
20. Performance Comparison Between Plasma and Stool Methylated
Liu Y; Zhao G; Miao J; Li H; Ma Y; Liu X; Li S; Zhu Y; Xiong S; Zheng M; Fei S
Front Genet; 2020; 11():324. PubMed ID: 32373158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]